Published in Biochem J on October 01, 1995
Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner. Arthritis Res Ther (2015) 0.82
Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages. Cell Death Differ (2016) 0.75
Polyamines. Annu Rev Biochem (1984) 12.92
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (1992) 12.92
Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J (1982) 8.16
Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J (1986) 6.09
Profound block in thymocyte development in mice lacking p56lck. Nature (1992) 5.48
Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol (1990) 5.27
Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell (1990) 4.84
Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes. Nature (1987) 3.50
Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med (1981) 3.27
Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. J Immunol (1986) 3.08
Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol (1980) 2.89
Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc Natl Acad Sci U S A (1989) 2.70
Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci (1990) 2.56
T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J Biol Chem (1989) 2.50
Tyrosine kinases and tyrosine-based activation motifs. Current research on activation via the T cell antigen receptor. J Biol Chem (1992) 2.05
The regulation and function of ornithine decarboxylase and of the polyamines. Curr Top Cell Regul (1979) 1.93
Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases. EMBO J (1987) 1.80
Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med (1993) 1.75
Control of ornithine decarboxylase in Chinese hamster ovary cells by polyamines. Translational inhibition of synthesis and acceleration of degradation of the enzyme by putrescine, spermidine, and spermine. J Biol Chem (1986) 1.41
Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse. J Immunol (1993) 1.33
Receptor tyrosine kinase substrates: src homology domains and signal transduction. FASEB J (1992) 1.30
Abnormal tyrosine phosphorylation on T-cell receptor in lymphoproliferative disorders. Nature (1987) 1.21
p56lck association with CD4 is required for the interaction between CD4 and the TCR/CD3 complex and for optimal antigen stimulation. J Immunol (1992) 1.15
Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis. J Clin Invest (1989) 0.99
T cell signaling. Science (1989) 0.98
Flow cytometric analysis of murine splenic B lymphocyte cytosolic free calcium response to anti-IgM and anti-IgD. Cytometry (1987) 0.97
Lpr T cell hyporesponsiveness to mitogens linked to deficient receptor-stimulated phosphoinositide hydrolysis. J Biol Chem (1988) 0.94
Successful treatment of lupus nephritis in MRL-lpr/lpr mice by inhibiting ornithine decarboxylase. Kidney Int (1991) 0.92
Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growth. Drug Metab Rev (1985) 0.92
Characterization of a phosphatidylinositol 4-phosphate-specific phosphomonoesterase in rat liver nuclear envelopes. Arch Biochem Biophys (1984) 0.91
Inhibition of calcium signalling in murine splenocytes by polyamines: differential effects on CD4 and CD8 T-cells. Biochem J (1993) 0.89
Multiple DNA elements responsible for transcriptional regulation of the ornithine decarboxylase gene by protein kinase A. J Biol Chem (1992) 0.88
Modulation of inositol phospholipid metabolism by polyamines. Biochem J (1988) 0.87
Polyamines in lymphocytes from patients infected by human immunodeficiency virus. Biol Chem Hoppe Seyler (1989) 0.85
Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice. J Immunol (1990) 0.82
alpha-Difluoromethylornithine alters calcium signaling in platelet-derived growth factor-stimulated A172 brain tumor cells in culture. Cancer Res (1992) 0.81
Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response. Cancer Res (1992) 0.81
Difluoromethylornithine therapy of female NZB/W mice. J Rheumatol (1991) 0.81
Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines. Cell Growth Differ (1995) 0.80
Molecular biology of cell activation. Exp Cell Res (1989) 0.80
Reduced tyrosine phosphorylation in polyamine-starved cells. Exp Cell Res (1992) 0.80
Reversal of the abnormal development of T cell subpopulations in the thymus of autoimmune MRL-lpr/lpr mice by a polyamine biosynthesis inhibitor. Autoimmunity (1992) 0.79
Regulation of ornithine decarboxylase in the kidney of autoimmune mice with the lpr gene. Autoimmunity (1994) 0.78
Polyamines and the catalytic domain of protein kinase C. Life Sci (1988) 0.77
Beneficial effects of a polyamine biosynthesis inhibitor on lupus in MRL-lpr/lpr mice. Clin Exp Immunol (1989) 0.76
The lymphocyte-specific tyrosine protein kinase p56lck. Cancer Invest (1991) 0.76
Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ (1998) 4.32
Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet (2000) 4.04
Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet (1997) 3.89
Purification of a pluripotent neural stem cell from the adult mouse brain. Nature (2001) 3.78
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet (1995) 3.33
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol (1993) 2.56
Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther (1991) 2.44
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum (2001) 2.11
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
Community outreach for untreated schizophrenia in rural India: a follow-up study of symptoms, disability, family burden and costs. Psychol Med (2005) 1.98
The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol (1998) 1.97
Regulatory mutants of polyoma virus defective in DNA replication and the synthesis of early proteins. Cell (1980) 1.85
Mice lacking HSP90beta fail to develop a placental labyrinth. Development (2000) 1.83
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum (2000) 1.82
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut (2002) 1.82
Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg (2000) 1.79
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum (1999) 1.75
Insulin sensitivity and cardiac autonomic function in young male practitioners of yoga. Natl Med J India (2009) 1.75
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Systematic review of the treatment of upper respiratory tract infection. Arch Dis Child (1998) 1.70
Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum (1989) 1.68
No exit? The effect of health status on dissatisfaction and disenrollment from health plans. Health Serv Res (1999) 1.64
Common amino acid sequence domains among the LEA proteins of higher plants. Plant Mol Biol (1989) 1.63
Rickets and secondary craniosynostosis associated with long-term antacid use in an infant. Arch Pediatr Adolesc Med (1998) 1.60
Viable deletion mutant in the medium and large T-antigen-coding sequences of the polyoma virus genome. J Virol (1980) 1.60
Ionic and structural specificity effects of natural and synthetic polyamines on the aggregation and resolubilization of single-, double-, and triple-stranded DNA. Biochemistry (1999) 1.53
Measurement of TG synthesis and turnover in vivo by 2H2O incorporation into the glycerol moiety and application of MIDA. Am J Physiol Endocrinol Metab (2003) 1.51
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
A link between adenosine, ATP-sensitive K+ channels, potassium and muscle vasodilatation in the rat in systemic hypoxia. J Physiol (1993) 1.47
Efficiency assessment of the gene trap approach. Dev Dyn (1998) 1.45
A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science (1999) 1.44
Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res (1999) 1.44
Preserved bone health in adolescent elite rhythmic gymnasts despite hypoleptinemia. Horm Res (2007) 1.43
[Use of isokinetic techniques vs standard physiotherapy in patients with chronic low back pain. Preliminary results]. Ann Readapt Med Phys (2004) 1.43
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum (2001) 1.42
Delayed healing of rhytidectomy flap resurfaced with CO2 laser. Plast Reconstr Surg (1998) 1.41
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol (1992) 1.41
Oral health: Dental neglect on wards. Br Dent J (2017) 1.40
Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology (2001) 1.40
Photopheresis for scleroderma? No! J Rheumatol (1992) 1.40
Oculonasal synkinesis. Plast Reconstr Surg (1994) 1.39
Anticoagulants: Updates on idarucizumab. Br Dent J (2017) 1.39
Are infants born in baby-friendly hospitals being exclusively breastfed until 6 months of age? Eur J Clin Nutr (2011) 1.38
Enhanced two-photon biosensing with double-clad photonic crystal fibers. Opt Lett (2003) 1.37
Uncx4.1 is required for the formation of the pedicles and proximal ribs and acts upstream of Pax9. Development (2000) 1.37
Why do levels of human welfare vary among nations? Int J Health Serv (1994) 1.36
Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis (2005) 1.35
The intravenous use of coconut water. Am J Emerg Med (2000) 1.34
Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin". Arthritis Rheum (1991) 1.28
Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations. Arthritis Rheum (1990) 1.27
Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis (2007) 1.26
Low temperature regulated DEAD-box RNA helicase from the Antarctic archaeon, Methanococcoides burtonii. J Mol Biol (2000) 1.24
The pathological basis and microanatomy of occlusive thrombus formation in human coronary arteries. Philos Trans R Soc Lond B Biol Sci (1981) 1.22
Digital sclerosis in children with insulin-dependent diabetes mellitus. Arthritis Rheum (1982) 1.22
Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther (1999) 1.22
Structure and expression of the rat transthyretin (prealbumin) gene. J Biol Chem (1988) 1.21
Phylogenetic relationship and antifouling activity of bacterial epiphytes from the marine alga Ulva lactuca. Environ Microbiol (2000) 1.20
European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill (2005) 1.20
Nucleotide sequence changes in polyoma virus A gene mutants. J Virol (1981) 1.19
Evaluation of a psycho-educational group programme for family caregivers in home-based palliative care. Palliat Med (2008) 1.19
The acute phase response in the rodent. Ann N Y Acad Sci (1989) 1.19
Germ line chimeras from female ES cells. Exp Cell Res (1997) 1.18
DNA condensation by polyamines: a laser light scattering study of structural effects. Biochemistry (2001) 1.17
Overexpression of White Collar-1 (WC-1) activates circadian clock-associated genes, but is not sufficient to induce most light-regulated gene expression in Neurospora crassa. Mol Microbiol (2002) 1.16
Taube nuss is a novel gene essential for the survival of pluripotent cells of early mouse embryos. Development (2000) 1.16
Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes. J Neurosci (2000) 1.16
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann Rheum Dis (2007) 1.14
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis. Arthritis Rheum (2012) 1.13
Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor. Arthritis Rheum (1984) 1.12
Corrugator supercilii muscle resection through blepharoplasty incision. Plast Reconstr Surg (1995) 1.12
Gene expression in regenerating and acute-phase rat liver. Am J Physiol (1990) 1.11
Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol (1995) 1.11
A source of adenosine involved in cardiovascular responses to defense area stimulation. Am J Physiol (1997) 1.09
The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)--quality of life during the first 4 months after fracture. Osteoporos Int (2013) 1.08
Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. J Bone Miner Res (2002) 1.07
Anticardiolipin antibodies in systemic sclerosis. Arthritis Rheum (1986) 1.07
Compensation for a gene trap mutation in the murine microtubule-associated protein 4 locus by alternative polyadenylation and alternative splicing. Dev Dyn (1998) 1.06
Real-time calculation of a limiting form of the Renyi entropy applied to detection of subtle changes in scattering architecture. J Acoust Soc Am (2009) 1.06
Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med (1988) 1.05
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Arthritis Rheum (1998) 1.05
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test. Ann Rheum Dis (2006) 1.05
Anthropometry and body composition of south Indian babies at birth. Public Health Nutr (2006) 1.04
Fibromatosis of the breast: a case report and literature review. J Surg Oncol (1987) 1.04
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study. Osteoporos Int (2011) 1.03
The effect of fish and omega-3 LCPUFA intake on low birth weight in Indian pregnant women. Eur J Clin Nutr (2007) 1.03
Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporos Int (2011) 1.00
Cold stress response in Archaea. Extremophiles (2000) 1.00
Proportion of lung cancers in males, due to occupation, in different areas of the USA. Int J Cancer (1988) 1.00
Lung cancer in motor exhaust-related occupations. Am J Ind Med (1989) 1.00
Muscle mass and functional correlates of insulin sensitivity in lean young Indian men. Eur J Clin Nutr (2009) 0.99
Cyclosporine in scleredema. J Am Acad Dermatol (1996) 0.99
Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis. Clin Exp Immunol (1984) 0.98
The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS. Mutagenesis (2008) 0.98
Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: tissue-specific regulation of estrogen receptor in CD1 mice. Toxicol Appl Pharmacol (1992) 0.97
Characterization of P2 receptors modulating neural activity in rat rostral ventrolateral medulla. Neuroscience (1999) 0.97
Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Euro Surveill (2004) 0.97
Soluble and cellular markers of immune activation in patients with systemic sclerosis. Clin Immunol Immunopathol (1990) 0.97
Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res (1998) 0.97
Incorporation of palmitate-1-14C into lung tissue and "alveolar" lecithin. Am J Physiol (1970) 0.97